[Guidelines of the Swiss Diabetic Association concerning oral antidiabetic agents].
D000284:Administration, Oral; D001645:Biguanides / Q000008:administration & dosage / Q000627:therapeutic use*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012955:Societies, Medical; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D013557:Switzerland
D001645:Biguanides; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds
Directives de l'ASD concernant les antidiabétiques oraux.